Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, and Organometallic Complex Synthesis and Catalysis.
A multimodal LLM-agent framework for personalized clinical decision-making in hepatocellular carcinoma
Validation of proposed imaging criteria for estimating vessels encapsulating tumor clusters in hepatocellular carcinoma at CT and gadoxetic acid-enhanced MRI
A Multi‐Scale Computational Model of the Hepatic Circulation Applied to Predict the Portal Pressure After Transjugular Intrahepatic Portosystemic Shunt (<scp>TIPS</scp>)
Association of blood cadmium levels with all-cause and cause-specific mortality among adults with non-alcoholic fatty liver disease: a prospective cohort study
Multimodal deep learning model for predicting prognosis following radiotherapy-based combination therapy in unresectable hepatocellular carcinoma
Anatomical resection is associated with reduced early recurrences in HCC: A machine learning analysis
A predictive nomogram for surgical site infection in patients who received clean orthopedic surgery: a retrospective study
A computational model-based study on the feasibility of predicting post-splenectomy thrombosis using hemodynamic metrics
Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study
Effect of skeletal muscle index on post-embolization syndrome of hepatocellular carcinoma after transarterial chemoembolization
One‐year status of hepatic venous pressure gradient measurement from 85 hospitals in China
Association of blood cadmium levels with all-cause and cause-specific mortality among adults with Non-Alcoholic Fatty Liver Disease: A prospective cohort study
Inversed albumin-to-globulin ratio and underlying liver disease severity as a prognostic factor for survival in hepatocellular carcinoma patients undergoing transarterial chemoembolization
Gallbladder neuroendocrine carcinoma: A report of two cases and literature review
Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
Effect of sarcopenia and albumin-bilirubin grade on survival in patients with hepatocellular carcinoma under transarterial chemoembolization
Anti-HBV Therapy in Hepatocellular Carcinoma May Affect the Symptoms of SARS-CoV-2 Infection
Meta‐analysis of the immunogenicity of standard and booster SARS‐CoV‐2 vaccination in patients with chronic liver disease and post‐liver transplantation
Corrigendum: Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: a multicenter study
Immunogenicity and safety of a booster COVID‐19 vaccination in patients with chronic liver disease: A multicenter study
LASSO-Based Machine Learning Model for Prediction of Liver Failure in Hepatocellular Carcinoma Patients Undergoing TACE
Preliminary exploration of a multidisciplinary management model for cirrhotic portal hypertension
An imaging-based artificial intelligence model for non-invasive grading of hepatic venous pressure gradient in cirrhotic portal hypertension
Nomogram Estimating Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma From Preoperative Gadoxetate Disodium‐Enhanced <scp>MRI</scp>
Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: A multicenter study
Preoperative Microvascular Invasion Prediction to Assist in Surgical Plan for Single Hepatocellular Carcinoma: Better Together with Radiomics
A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study
Development and validation of a machine learning–based model for varices screening in compensated cirrhosis (CHESS2001): an international multicenter study
Safety and immunogenicity of COVID‐19 vaccination in patients with hepatocellular carcinoma (CHESS‐NMCID 2101): A multicenter prospective study